Use your antibodies-online credentials, if available.
No Products on your Comparison List.
Your basket is empty.
Find out more
Show all species
Show all synonyms
Select your species and application
anti-Mouse (Murine) Antibodies:
anti-Rat (Rattus) Antibodies:
Go to our pre-filtered search.
Chicken Polyclonal STXBP1 Primary Antibody for WB - ABIN2475759
Pevsner, Hsu, Scheller: n-Sec1: a neural-specific syntaxin-binding protein. in Proceedings of the National Academy of Sciences of the United States of America 1994
Show all 3 Pubmed References
Human Polyclonal STXBP1 Primary Antibody for IHC (p), IHC - ABIN188542
Swanson, Steel, Valle: Identification and characterization of the human ortholog of rat STXBP1, a protein implicated in vesicle trafficking and neurotransmitter release. in Genomics 1998
Glucose-dependent de-SUMOylation of tomosyn1 at K298 releases syntaxin1A (show STX1A Antibodies) and controls the amplification of exocytosis in concert with a recently-identified tomosyn1-interacting partner; the Ca(2+)-binding protein (show PVALB Antibodies) secretagogin (show SCGN Antibodies), which dissociates from tomosyn1 in response to Ca(2 (show CA2 Antibodies)+)-raising stimuli and is required for insulin (show INS Antibodies) granule trafficking and exocytosis downstream of Ca(2 (show CA2 Antibodies)+) influx.
Significant alterations in protein expression were identified in each neuronal ceroid lipofuscinoses (NCLs), including reduced STXBP1 in CLN1 (show PPT1 Antibodies) disease brain. Given the confounding variable of post-mortem changes, additional validation is required, but this study provides a useful starting set of candidate NCL (show CLN5 Antibodies) biomarkers for further evaluation.
Mutated STXBP1 gene associated with early-onset Epileptic Encephalopathy and severe psychomotor development retardation that occurs within 3 months of age.
Mutations in STXBP1 encoding the syntaxin binding protein 1 can produce a phenotype similar to that of KCNQ2 (show KCNQ2 Antibodies) mutations
9q33.3q34.11 microdeletion including STXBP1 gene identified in four patients with intellectual disability, epilepsy, nail (show CD244 Antibodies) dysplasia and bone malformations.
We report the case of a 19-month-old child with Ohtahara syndrome who displays a previously unreported mutation in STXBP1 This mutation is located in a donor splice site and eliminates exon 14, resulting in a truncated protein
We conducted a cohort study to analyze STXBP1 in 42 patients with epileptic encephalopathy. We identified four novel mutations: two splicing mutations, a frameshift mutation, and a nonsense mutation.
Reduced expression of STXBP1 leads to changes in the expression and localization of syntaxin-1 (show STX1A Antibodies) in pluripotent stem cells from epileptic encephalopathy patient.
Seizure severity and intellectual disability were connected to STXBP1 encephalopathy patients.
partial STXBP1 loss of function robustly impairs neurotransmitter release in human neurons, and suggest that heterozygous STXBP1 mutations cause early epileptic encephalopathy specifically through a presynaptic impairment.
This study demonstrated that the disruption of Munc18-1 function may result in the abnormal corticogenesis, leading to neurodevelopmental disorders with MUNC18-1 gene abnormalities.
Findings suggest that synaptic impairments of the dorsal telencephalic and subcortical excitatory neurons cause learning deficits and enhanced aggression in Stxbp1+/- mice, respectively.
proteins, such as syntaxin-1, Munc18-1, or SNAP-25, modulate alpha-synuclein neuropathy and/or are dysregulated in Alzheimer's disease, understanding this type of neurodegeneration may provide new links between synaptic defects and neurodegeneration in humans
This results of study concluded that a conformational change within helix 12 is responsible for the essential postdocking role of Munc18-1 in neurosecretion.
In this studying the Munc18-1-/- nervous system, we demonstrate that synaptic activity is dispensable for the early formation of spinal motor circuits at the levels of axon guidance, differentiation of transcriptional identity, and mRNA expression.
Vamp2 (show VAMP2 Antibodies) mutations that impair Munc18-1 binding inhibit spontaneous as well as evoked neurotransmitter release, providing evidence for the Vamp2 (show VAMP2 Antibodies)-regulating function of Munc18-1 in synaptic exocytosis.
A dynamic PKC (show PKC Antibodies) phosphorylation/de-phosphorylation cycle of Munc18-1 drives short-term enhancement of transmitter release during post-tetanic potentiation.
miR (show MLXIP Antibodies)-218 and miR (show MLXIP Antibodies)-322 directly interact with Stxbp1 by targeting the 3'UTR (show UTS2R Antibodies) of its mRNA.
Munc18-1 levels correlate with synaptic strength.
Syntaxin binding protein 1 is not required for allergic inflammation via IgE-mediated mast cell activation.
Epilepsy, Behavioral Abnormalities, and Physiological Comorbidities in Syntaxin-Binding Protein 1 (STXBP1) Mutant Zebrafish.
This gene encodes a syntaxin-binding protein. The encoded protein appears to play a role in release of neurotransmitters via regulation of syntaxin, a transmembrane attachment protein receptor. Mutations in this gene have been associated with infantile epileptic encephalopathy-4. Alternatively spliced transcript variants have been described.
, neuronal SEC1
, protein unc-18 homolog 1
, protein unc-18 homolog A
, syntaxin-binding protein 1
, UNC-18 homolog
, minisatellite 10g detected by probe MMS10
, unc-18 homolog
, syntaxin 1-binding protein
, syntaxin binding protein 1
, Ras opposite
, syntaxin-binding protein 1-like